Bafna Pharmaceuticals Limited (NSE:BAFNAPH)

Market Cap	4.84B +165.7%
Revenue (ttm)	1.51B +3.3%
Net Income	111.00M +167.3%
EPS	4.69 +167.2%
Shares Out	23.66M
PE Ratio	43.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,397
Open	200.65
Previous Close	200.60
Day's Range	200.65 - 204.61
52-Week Range	78.18 - 227.00
Beta	0.08
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1981
• Employees: 406
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BAFNAPH

Financial Performance

In fiscal year 2026, Bafna Pharmaceuticals's revenue was 1.51 billion, an increase of 3.26% compared to the previous year's 1.46 billion. Earnings were 111.00 million, an increase of 167.30%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 10, 2026

Data Sources Report a data error